 Donghoon Yoon
Concepts (218)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Erythropoietin | 6 | 2015 | 13 | 1.000 |
Why?
| | Gene Expression Regulation | 9 | 2015 | 964 | 0.850 |
Why?
| | Erythropoietin | 6 | 2015 | 51 | 0.820 |
Why?
| | Polycythemia | 6 | 2015 | 9 | 0.810 |
Why?
| | Erythroid Precursor Cells | 8 | 2015 | 15 | 0.610 |
Why?
| | Thymus Gland | 1 | 2018 | 42 | 0.590 |
Why?
| | Parathyroidectomy | 1 | 2018 | 46 | 0.590 |
Why?
| | Thyroidectomy | 1 | 2018 | 60 | 0.580 |
Why?
| | Hemoglobins | 2 | 2015 | 106 | 0.560 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2015 | 55 | 0.560 |
Why?
| | Parathyroid Hormone | 1 | 2018 | 147 | 0.550 |
Why?
| | Signal Transduction | 6 | 2015 | 1625 | 0.530 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 152 | 0.460 |
Why?
| | Lung Neoplasms | 3 | 2024 | 600 | 0.440 |
Why?
| | Erythropoiesis | 5 | 2015 | 16 | 0.440 |
Why?
| | Mice | 14 | 2024 | 5688 | 0.420 |
Why?
| | Oxylipins | 1 | 2010 | 3 | 0.360 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2011 | 3 | 0.360 |
Why?
| | Hematopoiesis | 1 | 2011 | 71 | 0.360 |
Why?
| | Cyclopentanes | 1 | 2010 | 10 | 0.360 |
Why?
| | Cell Hypoxia | 1 | 2011 | 82 | 0.360 |
Why?
| | Iron | 3 | 2011 | 122 | 0.350 |
Why?
| | Animals | 16 | 2024 | 13173 | 0.340 |
Why?
| | Calcium | 2 | 2024 | 401 | 0.340 |
Why?
| | Immunity, Innate | 1 | 2010 | 105 | 0.330 |
Why?
| | Organ Size | 1 | 2010 | 223 | 0.330 |
Why?
| | Anti-Inflammatory Agents | 1 | 2010 | 162 | 0.320 |
Why?
| | Polycythemia Vera | 4 | 2011 | 6 | 0.320 |
Why?
| | NF-kappa B | 1 | 2010 | 315 | 0.320 |
Why?
| | Macrophages | 2 | 2010 | 363 | 0.310 |
Why?
| | GATA1 Transcription Factor | 1 | 2008 | 7 | 0.300 |
Why?
| | Integrases | 1 | 2008 | 43 | 0.300 |
Why?
| | Bone Marrow Cells | 1 | 2008 | 190 | 0.280 |
Why?
| | Trans-Activators | 2 | 2009 | 135 | 0.280 |
Why?
| | Spleen | 1 | 2008 | 170 | 0.280 |
Why?
| | Transcription Factors | 1 | 2010 | 566 | 0.260 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 424 | 0.260 |
Why?
| | Erythrocytes | 2 | 2015 | 83 | 0.250 |
Why?
| | Biosensing Techniques | 1 | 2024 | 26 | 0.240 |
Why?
| | MicroRNAs | 5 | 2015 | 350 | 0.230 |
Why?
| | STAT5 Transcription Factor | 4 | 2015 | 10 | 0.230 |
Why?
| | Proto-Oncogene Proteins | 3 | 2011 | 156 | 0.230 |
Why?
| | Lymphoma | 1 | 2024 | 65 | 0.210 |
Why?
| | Milk Proteins | 1 | 2003 | 77 | 0.210 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2013 | 8 | 0.210 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 104 | 0.210 |
Why?
| | Hematopoietic Stem Cells | 1 | 2003 | 182 | 0.200 |
Why?
| | Genotype | 4 | 2018 | 539 | 0.200 |
Why?
| | Mutation | 5 | 2012 | 1292 | 0.180 |
Why?
| | Mice, Transgenic | 2 | 2015 | 543 | 0.180 |
Why?
| | Janus Kinase 2 | 3 | 2011 | 25 | 0.180 |
Why?
| | Cell Differentiation | 4 | 2010 | 651 | 0.170 |
Why?
| | Oligopeptides | 2 | 2018 | 95 | 0.170 |
Why?
| | Erythroid Cells | 2 | 2010 | 5 | 0.170 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 1785 | 0.170 |
Why?
| | Multiple Myeloma | 4 | 2018 | 2949 | 0.160 |
Why?
| | Humans | 20 | 2024 | 50389 | 0.140 |
Why?
| | DNA, Neoplasm | 1 | 2018 | 146 | 0.140 |
Why?
| | Collagen | 1 | 2018 | 208 | 0.140 |
Why?
| | Calcification, Physiologic | 1 | 2017 | 40 | 0.140 |
Why?
| | Neoplasm, Residual | 1 | 2018 | 161 | 0.140 |
Why?
| | Pelvis | 1 | 2017 | 67 | 0.140 |
Why?
| | Phosphorylation | 2 | 2015 | 527 | 0.130 |
Why?
| | Hematocrit | 1 | 2015 | 45 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 2 | 2024 | 186 | 0.130 |
Why?
| | Anemia | 1 | 2015 | 66 | 0.120 |
Why?
| | Osteogenesis | 1 | 2018 | 353 | 0.120 |
Why?
| | Catalase | 1 | 2015 | 68 | 0.120 |
Why?
| | Mutation, Missense | 2 | 2013 | 104 | 0.120 |
Why?
| | Cell Line | 3 | 2015 | 1010 | 0.110 |
Why?
| | Receptor, Parathyroid Hormone, Type 1 | 1 | 2013 | 24 | 0.110 |
Why?
| | Cell Line, Tumor | 4 | 2024 | 1399 | 0.110 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 406 | 0.110 |
Why?
| | Leukemia, Erythroblastic, Acute | 2 | 2010 | 4 | 0.110 |
Why?
| | Proteasome Inhibitors | 1 | 2013 | 104 | 0.100 |
Why?
| | Brain | 2 | 2011 | 1313 | 0.100 |
Why?
| | Fluorescent Dyes | 2 | 2024 | 105 | 0.090 |
Why?
| | Pluripotent Stem Cells | 1 | 2011 | 6 | 0.090 |
Why?
| | Cell Lineage | 1 | 2011 | 83 | 0.090 |
Why?
| | Protein Isoforms | 1 | 2011 | 118 | 0.090 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 40 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 51 | 0.090 |
Why?
| | Antigens, CD34 | 1 | 2010 | 65 | 0.090 |
Why?
| | Syndrome | 1 | 2011 | 239 | 0.090 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 96 | 0.090 |
Why?
| | Blood Glucose | 1 | 2012 | 443 | 0.080 |
Why?
| | Gene Expression | 2 | 2013 | 613 | 0.080 |
Why?
| | Erythroblasts | 1 | 2009 | 2 | 0.080 |
Why?
| | Kringles | 1 | 2009 | 1 | 0.080 |
Why?
| | Prions | 1 | 2009 | 7 | 0.080 |
Why?
| | Lipopolysaccharides | 1 | 2010 | 196 | 0.080 |
Why?
| | Prion Diseases | 1 | 2009 | 5 | 0.080 |
Why?
| | STAT3 Transcription Factor | 1 | 2009 | 80 | 0.080 |
Why?
| | Neuroblastoma | 1 | 2009 | 52 | 0.080 |
Why?
| | Liver | 2 | 2012 | 1123 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2010 | 257 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2018 | 1589 | 0.080 |
Why?
| | Female | 9 | 2018 | 26981 | 0.080 |
Why?
| | Antibody Specificity | 1 | 2008 | 35 | 0.080 |
Why?
| | Blood Group Antigens | 1 | 2008 | 4 | 0.080 |
Why?
| | Oxygen | 1 | 2011 | 321 | 0.080 |
Why?
| | Cross Reactions | 1 | 2008 | 41 | 0.080 |
Why?
| | beta-Galactosidase | 1 | 2008 | 35 | 0.070 |
Why?
| | Cell Proliferation | 4 | 2013 | 989 | 0.070 |
Why?
| | Transfection | 2 | 2010 | 354 | 0.070 |
Why?
| | Genetic Diseases, Inborn | 1 | 2007 | 23 | 0.070 |
Why?
| | Cytokines | 1 | 2010 | 606 | 0.070 |
Why?
| | Cation Transport Proteins | 1 | 2007 | 27 | 0.070 |
Why?
| | Middle Aged | 5 | 2018 | 12460 | 0.070 |
Why?
| | Zebrafish | 1 | 2007 | 54 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 269 | 0.070 |
Why?
| | Models, Animal | 1 | 2007 | 228 | 0.070 |
Why?
| | Granulocytes | 3 | 2013 | 26 | 0.070 |
Why?
| | Adult | 5 | 2018 | 13568 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2008 | 482 | 0.070 |
Why?
| | Yolk Sac | 1 | 2006 | 10 | 0.070 |
Why?
| | Kidney | 1 | 2011 | 686 | 0.070 |
Why?
| | Piperazines | 1 | 2007 | 118 | 0.070 |
Why?
| | Isoantigens | 1 | 2006 | 9 | 0.070 |
Why?
| | Survival Analysis | 1 | 2008 | 671 | 0.070 |
Why?
| | Proteins | 1 | 2009 | 350 | 0.070 |
Why?
| | Male | 7 | 2018 | 25718 | 0.060 |
Why?
| | Pyrimidines | 1 | 2007 | 193 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 467 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2006 | 95 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2007 | 205 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2006 | 120 | 0.060 |
Why?
| | Mice, Knockout | 1 | 2008 | 840 | 0.060 |
Why?
| | Disease Progression | 1 | 2008 | 823 | 0.060 |
Why?
| | Stem Cells | 1 | 2006 | 171 | 0.060 |
Why?
| | Coated Materials, Biocompatible | 1 | 2024 | 34 | 0.060 |
Why?
| | Luminescent Proteins | 1 | 2024 | 55 | 0.060 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 244 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 98 | 0.060 |
Why?
| | Tyrosine | 1 | 2003 | 95 | 0.050 |
Why?
| | Reticulocytes | 2 | 2015 | 9 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2007 | 830 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 294 | 0.050 |
Why?
| | Homozygote | 2 | 2013 | 56 | 0.050 |
Why?
| | Prognosis | 1 | 2008 | 1979 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2003 | 579 | 0.050 |
Why?
| | Cell Survival | 1 | 2003 | 590 | 0.050 |
Why?
| | Base Sequence | 2 | 2013 | 657 | 0.040 |
Why?
| | K562 Cells | 2 | 2010 | 41 | 0.040 |
Why?
| | Alleles | 2 | 2012 | 253 | 0.040 |
Why?
| | Phenotype | 2 | 2013 | 736 | 0.040 |
Why?
| | Proline | 1 | 2018 | 30 | 0.040 |
Why?
| | Amino Acid Substitution | 2 | 2011 | 81 | 0.040 |
Why?
| | Proteolysis | 1 | 2018 | 96 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2018 | 108 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 409 | 0.040 |
Why?
| | Cell Movement | 1 | 2018 | 246 | 0.040 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 94 | 0.030 |
Why?
| | Up-Regulation | 2 | 2010 | 449 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 152 | 0.030 |
Why?
| | Bone Resorption | 1 | 2018 | 302 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2010 | 1148 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 267 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2010 | 1029 | 0.030 |
Why?
| | Aged | 2 | 2018 | 9590 | 0.030 |
Why?
| | Croatia | 1 | 2013 | 3 | 0.030 |
Why?
| | Russia | 1 | 2013 | 10 | 0.030 |
Why?
| | Boronic Acids | 1 | 2013 | 182 | 0.030 |
Why?
| | Pyrazines | 1 | 2013 | 187 | 0.030 |
Why?
| | Time Factors | 2 | 2011 | 2934 | 0.030 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2012 | 3 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2012 | 5 | 0.030 |
Why?
| | Pedigree | 1 | 2013 | 125 | 0.030 |
Why?
| | Haplotypes | 1 | 2013 | 82 | 0.030 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2012 | 9 | 0.030 |
Why?
| | Family Health | 1 | 2013 | 78 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 176 | 0.030 |
Why?
| | Mitochondria | 1 | 2015 | 398 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 578 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 1160 | 0.020 |
Why?
| | Hematopoietic System | 1 | 2011 | 3 | 0.020 |
Why?
| | Dioxygenases | 1 | 2011 | 3 | 0.020 |
Why?
| | Chromosomes, Human, X | 1 | 2011 | 18 | 0.020 |
Why?
| | Clone Cells | 1 | 2011 | 78 | 0.020 |
Why?
| | Hemin | 1 | 2010 | 8 | 0.020 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2010 | 32 | 0.020 |
Why?
| | Cytoplasm | 1 | 2010 | 93 | 0.020 |
Why?
| | Insulin | 1 | 2012 | 466 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 249 | 0.020 |
Why?
| | Friend murine leukemia virus | 1 | 2009 | 2 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1356 | 0.020 |
Why?
| | Plasminogen | 1 | 2009 | 2 | 0.020 |
Why?
| | Prothrombin | 1 | 2009 | 4 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 5 | 0.020 |
Why?
| | Cell Membrane | 1 | 2010 | 249 | 0.020 |
Why?
| | Genes, myb | 1 | 2009 | 1 | 0.020 |
Why?
| | Hepatocyte Growth Factor | 1 | 2009 | 9 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 17 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 297 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2013 | 1419 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2009 | 117 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2011 | 331 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 197 | 0.020 |
Why?
| | Blood Platelets | 1 | 2011 | 252 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 475 | 0.020 |
Why?
| | Tissue Plasminogen Activator | 1 | 2009 | 110 | 0.020 |
Why?
| | Binding Sites | 1 | 2009 | 378 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 227 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2007 | 25 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2007 | 36 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2007 | 113 | 0.020 |
Why?
| | Protein Binding | 1 | 2009 | 657 | 0.020 |
Why?
| | Benzamides | 1 | 2007 | 51 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 781 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2007 | 272 | 0.020 |
Why?
| | GPI-Linked Proteins | 1 | 2006 | 30 | 0.020 |
Why?
| | Valine | 1 | 2006 | 57 | 0.020 |
Why?
| | Phenylalanine | 1 | 2006 | 131 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2006 | 178 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 1101 | 0.010 |
Why?
| | Child, Preschool | 1 | 2010 | 3908 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 4064 | 0.010 |
Why?
| | Adolescent | 1 | 2010 | 6475 | 0.010 |
Why?
|
|
Yoon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|